Agribusiness giant Monsanto is appealing a $78 million verdict in favor of a dying California man who said the company’s widely used Roundup weed killer was a major factor in his cancer.
The company filed a notice of appeal Tuesday in San Francisco Superior Court challenging the August jury verdict in favor of DeWayne Johnson.
Bayer, which acquired Monsanto in June, said in a statement that none of the science presented at trial supports the conclusion that Roundup was a substantial cause of Johnson’s non-Hodgkin’s lymphoma.
An email to a spokeswoman for Johnson’s attorneys was not immediately returned.
Bayer says numerous studies have shown glyphosate, the active ingredient in the weed killer, is safe when used properly.
This article provided by NewsEdge.